APOB and atherosclerosis: Consistent with the hypothesis that a significant number of mechanisms underlying atherosclerosis and ACS without SMuRFs remains undiscovered, our study will be the first to elaborate metabolomic and inflammatory biomarkers, such as Lp(a), ApoB and ApoA1 interleukin-6 (IL-6) and suPAR.